Compare EME & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EME | IQV |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | United States | United States |
| Employees | 25000 | 93000 |
| Industry | Engineering & Construction | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2B | 27.7B |
| IPO Year | 1994 | 2013 |
| Metric | EME | IQV |
|---|---|---|
| Price | $741.72 | $167.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $831.67 | $230.56 |
| AVG Volume (30 Days) | 338.5K | ★ 2.0M |
| Earning Date | 06-01-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 30.99 | 4.67 |
| EPS | ★ 28.19 | 7.84 |
| Revenue | ★ $16,986,422,000.00 | $9,739,000,000.00 |
| Revenue This Year | $7.48 | $6.76 |
| Revenue Next Year | $7.51 | $5.85 |
| P/E Ratio | $25.82 | ★ $21.60 |
| Revenue Growth | 16.62 | ★ 41.60 |
| 52 Week Low | $320.89 | $134.65 |
| 52 Week High | $835.00 | $247.05 |
| Indicator | EME | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 52.11 | 39.82 |
| Support Level | $600.37 | $156.43 |
| Resistance Level | $747.78 | $193.26 |
| Average True Range (ATR) | 21.46 | 6.02 |
| MACD | -2.51 | 1.28 |
| Stochastic Oscillator | 83.49 | 25.35 |
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.